SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Berta Sáez-Giménez, Cristina Berastegui, Karina Loor, Manuel López-Meseguer, Víctor Monforte, Carlos Bravo, Amparo Santamaría, Antonio Roman, Deep vein thrombosis and pulmonary embolism after solid organ transplantation: an unresolved problem, Transplantation Reviews, 2015, 29, 2, 85

    CrossRef

  2. 2
    Benjamin T. Duhart, Winston A. Ally, Amy G. Krauss, Joanna Q. Hudson, James D. Eason, Vinaya Rao, Jason M. Vanatta, The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period, Journal of Transplantation, 2015, 2015, 1

    CrossRef

  3. 3
    Greg J. McKenna, Göran B.G. Klintmalm, Transplantation of the Liver, 2015,

    CrossRef

  4. 4
    S. K. Asrani, R. H. Wiesner, J. F. Trotter, G. Klintmalm, E. Katz, E. Maller, J. Roberts, N. Kneteman, L. Teperman, J. J. Fung, J. M. Millis, De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial, American Journal of Transplantation, 2014, 14, 2
  5. 5
    Goran B. Klintmalm, Björn Nashan, The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence, Journal of Transplantation, 2014, 2014, 1

    CrossRef

  6. 6
    Lewis Teperman, Dilip Moonka, Anthony Sebastian, Linda Sher, Paul Marotta, Christopher Marsh, Baburao Koneru, John Goss, Dennis Preston, John P. Roberts, Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial, Liver Transplantation, 2013, 19, 7
  7. 7
    Goran Klintmalm, Cliona O'Farrelly, Taking the rap: Multiple effects of blocking mammalian target of rapamycin, Hepatology, 2013, 57, 1
  8. 8
    D. A. Potter, D. Yee, Z. Guo, M. Rodriguez, Should diabetic women with breast cancer have their own intervention studies?, Endocrine Related Cancer, 2012, 19, 1, C13

    CrossRef

  9. 9
    Greg J. McKenna, James F. Trotter, Sirolimus – It doesn’t deserve its bad Rap(a), Journal of Hepatology, 2012, 56, 1, 285

    CrossRef

  10. 10
    G. J. McKenna, J. F. Trotter, Sirolimus Conversion for Renal Dysfunction in Liver Transplant Recipients: The Devil Really Is in the Details…, American Journal of Transplantation, 2012, 12, 3
  11. 11
    Jennifer T. Thibodeau, Joseph D. Mishkin, Parag C. Patel, Patricia A. Kaiser, Colby R. Ayers, Pradeep P. A. Mammen, David W. Markham, W. Steves Ring, Matthias Peltz, Mark H. Drazner, Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients, Clinical Transplantation, 2012, 26, 6
  12. 12
    Omar Massoud, Russell H. Wiesner, The use of Sirolimus should be restricted in liver transplantation, Journal of Hepatology, 2012, 56, 1, 288

    CrossRef

  13. 13
    Jeffrey Campsen, Michael A. Zimmerman, Susan Mandell, Maria Kaplan, Igal Kam, A Decade of Experience Using mTor Inhibitors in Liver Transplantation, Journal of Transplantation, 2011, 2011, 1

    CrossRef

  14. 14
    Maria-Sole Basso, Pushpa Subramaniam, Mike Tredger, Anita Verma, Nigel Heaton, Mohamed Rela, Giorgina Mieli-Vergani, Anil Dhawan, Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients, Pediatric Transplantation, 2011, 15, 7
  15. 15
    Luit Penninga, Andre Wettergren, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipients, The Cochrane Library,
  16. 16
    Russell H. Wiesner, Immunosuppression: The Global Picture,